Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion description "[Thus, attenuation of MCP-1 upregulation by inhibiting ERK phosphorylation might be a promising approach to treat CMT1X and other so far untreatable inherited peripheral neuropathies in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion evidence source_evidence_literature NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion SIO_000772 20591826 NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion wasDerivedFrom befree-20150227 NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion wasGeneratedBy ECO_0000203 NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- befree-20150227 importedOn "2015-02-27" NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.